Cargando…
DIAPH1 mediates progression of atherosclerosis and regulates hepatic lipid metabolism in mice
Atherosclerosis evolves through dysregulated lipid metabolism interwoven with exaggerated inflammation. Previous work implicating the receptor for advanced glycation end products (RAGE) in atherosclerosis prompted us to explore if Diaphanous 1 (DIAPH1), which binds to the RAGE cytoplasmic domain and...
Autores principales: | Senatus, Laura, Egaña-Gorroño, Lander, López-Díez, Raquel, Bergaya, Sonia, Aranda, Juan Francisco, Amengual, Jaume, Arivazhagan, Lakshmi, Manigrasso, Michaele B., Yepuri, Gautham, Nimma, Ramesh, Mangar, Kaamashri N., Bernadin, Rollanda, Zhou, Boyan, Gugger, Paul F., Li, Huilin, Friedman, Richard A., Theise, Neil D., Shekhtman, Alexander, Fisher, Edward A., Ramasamy, Ravichandran, Schmidt, Ann Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10023694/ https://www.ncbi.nlm.nih.gov/pubmed/36932214 http://dx.doi.org/10.1038/s42003-023-04643-2 |
Ejemplares similares
-
Disruption of the productive encounter complex results in dysregulation of DIAPH1 activity
por: Theophall, Gregory G., et al.
Publicado: (2023) -
Inflammation Meets Metabolism: Roles for the Receptor for Advanced Glycation End Products Axis in Cardiovascular Disease
por: Senatus, Laura, et al.
Publicado: (2021) -
DIAPH1-MFN2 interaction regulates mitochondria-SR/ER contact and modulates ischemic/hypoxic stress
por: Yepuri, Gautham, et al.
Publicado: (2023) -
Receptor for Advanced Glycation End Products (RAGE) and Mechanisms and Therapeutic Opportunities in Diabetes and Cardiovascular Disease: Insights From Human Subjects and Animal Models
por: Egaña-Gorroño, Lander, et al.
Publicado: (2020) -
Small Molecule Inhibition of Ligand-Stimulated RAGE-DIAPH1 Signal Transduction
por: Manigrasso, Michaele B., et al.
Publicado: (2016)